Tag: Biological E
CDSCO nod to Biological E’s pneumonia vaccine for infants
BE’s PCV14 is comparable in terms of serotype coverage for infants to the two pneumococcal conjugate vaccines Prevnar13 and Merck’s VAXNEUVANCE, which are currently approved globally
Biological E slashes Corbevax price to Rs 250
The reduction in price will result in end users paying a price of ₹400 a dose which will include the taxes and administration charges
BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic
Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India
Biological E gets DCGI nod for phase 2/3 trials of its...
The prospective, randomized, double-blind, placebo controlled, phase-2/3 trials of 'Corbevax' will be conducted across 10 sites in the country...................
Scale up the production capacity: PM Modi tells vaccine manufacturers
The prime minister, Narendra Modi interacted with vaccine manufacturers from across the country on April 20, 2021........................
Biological E begins clinical trials of its COVID-19 vaccine
The results of this clinical trial are expected to be available by February 2021..................
Biological E unveils its Typhoid Conjugate Vaccine, manufacturing plant at Genome...
Biological E has invested Rs 300 Crore to build this Plant that will produce the Typhoid Conjugate Vaccine to protect children against typhoid fever, also generating employment for about 1000 people................